Accessibility Menu

MicroPort Scientific(FRA) MSK

Market Cap€1.25BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
€0.65
-2.26%
-0.02Today

MicroPort Scientific Financials at a Glance

Market Cap

€1.25BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

€0.01

P/E Ratio

31.40

Dividend

€0.00

Beta (Volatility)

0.06 (Low)

Price

€0.65

Volume

0

Open

€0.65

Previous Close

€0.65

Daily Range

€0.65 - €0.65

52-Week Range

€0.64 - €1.75

Estimated Earnings Date

N/A

MSK News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About MicroPort Scientific

MicroPort Scientific Corp. operates as an investment holding company. The firm engages in the research and development, manufacture and distribution of medical devices. It operates through the following segments: Cardiovascular Devices Business, Orthopedics Devices Business, Cardiac Rhythm Management Business, Endovascular Devices Business, Neurovascular Devices Business, Surgical Devices Business, Heart Valve Business and Surgical Robot Devices Business. The Cardiovascular Devices Business segment engages in the sale, manufacture, research and development of cardiovascular devices, such as drug eluting stents. The Orthopedics Devices Business segment engages in the sale, manufacture, research and development of orthopedics devices. The Cardiac Rhythm Management Business segment engages in the sale, manufacture, research and development of cardiac rhythm management devices. The Endovascular Devices Business segment engages in the sale, manufacture, research and development of endovascular devices. The Neurovascular Devices Business segment engages in the sale, manufacture, research and development of neurovascular devices. The Surgical Devices Business segment engages in the sale, manufacture, research and development of surgical devices. The Heart Valve Business segment engages in the sale, manufacture, research and development of heart valve devices. The Surgical Robot Devices Business segment engages in the sale, manufacture, research and development of surgical robot devices. The company was founded by Zhaohua Chang in 1998 and is headquartered in Shanghai, China.

Industry

Healthcare Equipment and Supplies

Employees

6,547

CEO

Zhao Hua Chang, PhD; Jonathan W. Chen

MSK Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

-28.67%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

3.18%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€1.25BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.92B

Volume

0

Avg. Volume

69.167

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

MicroPort Scientific Performance Analysis

MicroPort Scientific annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 800,049,04721.4%
20232023-12-31EUR 879,392,5449.9%
20242024-12-31EUR 854,559,397-2.8%
20252025-12-31EUR 881,559,8423.2%
MicroPort Scientific annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR -0.2469.7%
20232023-12-31EUR -0.255.9%
20242024-12-31EUR -0.11-55.3%
20252025-12-31EUR 0.01N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

€1.25BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
WETOWetour Robotics
$5.48-0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$71.92+0.00%
IBITiShares Bitcoin Trust
$44.67+0.02%
INTCIntel
$89.51+0.00%

Questions About MSK

What is the current price of MicroPort Scientific?

MicroPort Scientific is trading at €0.65 per share.

What is the 52-week range for MicroPort Scientific?

Over the past 52 weeks, MicroPort Scientific has traded between €0.64 and €1.75.

How much debt does MicroPort Scientific have?

As of the most recent reporting period, MicroPort Scientific reported total debt of €1.36B.

How much cash does MicroPort Scientific have on hand?

MicroPort Scientific reported €584.01M in cash and cash equivalents in its most recent financial results.

What is MicroPort Scientific’s dividend yield?

MicroPort Scientific does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.